Public Profile

Certara

Certara, a leading global provider of biosimulation and drug development solutions, is headquartered in the United States. Founded in 2008, the company has established itself as a pivotal player in the pharmaceutical and biotechnology industries, offering innovative services that enhance drug development processes. With a strong presence in North America, Europe, and Asia, Certara focuses on pharmacokinetics, pharmacodynamics, and regulatory science, providing advanced modelling and simulation tools. Their core products, including Phoenix® and Simcyp®, are renowned for their ability to streamline drug development and improve decision-making, setting them apart in a competitive market. Certara's commitment to scientific excellence has earned it a prominent position in the industry, with numerous accolades recognising its contributions to accelerating drug development and improving patient outcomes.

DitchCarbon Score

How does Certara's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

6

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Certara's score of 6 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

43%

Certara's reported carbon emissions

In 2022, Certara, headquartered in the United States, reported total carbon emissions of approximately 1,109,190 kg CO2e, which includes both Scope 1 and Scope 2 emissions. Specifically, Scope 1 emissions amounted to about 441,770 kg CO2e, with 46,910 kg CO2e from fugitive emissions and 394,860 kg CO2e from stationary combustion. Scope 2 emissions totalled approximately 1,127,010 kg CO2e, primarily from purchased electricity, which accounted for about 685,240 kg CO2e. Certara has committed to reducing its carbon footprint, although specific reduction targets have not been disclosed. The company is currently classified as "Committed" to near-term reduction initiatives, indicating a proactive stance towards addressing its climate impact. However, it has not yet set a net-zero target or a long-term reduction goal. As a participant in the software and services sector, Certara's climate commitments reflect a growing trend among companies to enhance sustainability practices and reduce greenhouse gas emissions.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

Add to project
2022
Scope 1
441,770
Scope 2
1,127,010
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Certara's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Certara is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Certara is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

CDP

Genmab

DK
Medical Device Manufacturing
Updated 11 days ago

Artemis Optical Holdings Ltd

GB
Medical Device Manufacturing
Updated 3 days ago

Innovative Trials Limited

GB
Medical Device Manufacturing
Updated 11 days ago

4D Technology Corporation

US
Medical Device Manufacturing
Updated 3 days ago

Bain Medical Equipment

CN
Medical Device Manufacturing
Updated 11 days ago

JENOPTIK unique-mode GmbH

DE
Medical Device Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers